E. Crinière

发表

Genomic changes in progression of low-grade gliomas

K. Hoang-Xuan, F. Ducray, Y. Marie, 2008, Journal of Neuro-Oncology.

Prognostic stratification of gliomatosis cerebri by IDH1R132H and INA expression

K. Hoang-Xuan, F. Ducray, M. Sanson, 2011, Journal of Neuro-Oncology.

MGMT methylation: A marker of response to temozolomide in low‐grade gliomas

K. Hoang-Xuan, Y. Marie, M. Sanson, 2006, Annals of neurology.

Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas

K. Hoang-Xuan, L. Hesson, I. Bièche, 2004, Oncogene.

Specific chromosomal imbalances as detected by array CGH in ependymomas in association with tumor location, histological subtype and grade

F. Ducray, A. Idbaih, A. Jouvet, 2010, Journal of Neuro-Oncology.

Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.

K. Hoang-Xuan, C. Duyckaerts, F. Ducray, 2011, European journal of cancer.

MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities

K. Hoang-Xuan, M. Sanson, K. Mokhtari, 2007, Journal of Neuro-Oncology.

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas.

K. Hoang-Xuan, I. Gut, Y. Marie, 2009, Neuro-oncology.

Distinct Responses of Xenografted Gliomas to Different Alkylating Agents Are Related to Histology and Genetic Alterations

Y. Marie, M. Sanson, J. Golmard, 2004, Cancer Research.

Analysis of the bHLH Transcription Factors Olig1 and Olig2 in Brain Tumors

K. Hoang-Xuan, Y. Marie, M. Sanson, 2004, Journal of Neuro-Oncology.

Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice

Y. Marie, M. Sanson, M. Poupon, 2003, British Journal of Cancer.

Multidrug Resistance-Associated Protein MRP1 Expression in Human Gliomas: Chemosensitization to Vincristine and Etoposide by Indomethacin in Human Glioma Cell Lines Overexpressing MRP1

J. Bernaudin, K. Mokhtari, J. Delattre, 2004, Journal of Neuro-Oncology.

Influence of MDM2 SNP309 alone or in combination with the TP53 R72P polymorphism in oligodendroglial tumors

K. Hoang-Xuan, Y. Marie, M. Sanson, 2008, Brain Research.

Correlations between molecular profile and radiologic pattern in oligodendroglial tumors

H Duffau, P Broët, K. Hoang-Xuan, 2004, Neurology.

TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.

K. Hoang-Xuan, F. Ducray, Y. Marie, 2007, Cancer genetics and cytogenetics.

Telomerase reactivation in malignant gliomas and loss of heterozygosity on 10p15.1

K. Hoang-Xuan, M. Sanson, J. Golmard, 2003, Neurology.

Array‐Based Genomics in Glioma Research

K. Ligon, O. Delattre, A. Idbaih, 2010, Brain pathology.

α-Internexin expression identifies 1p19q codeleted gliomas

K. Hoang-Xuan, F. Ducray, Y. Marie, 2009, Neurology.

Gene amplification is a poor prognostic factor in anaplastic oligodendrogliomas.

K. Hoang-Xuan, Y. Marie, M. Sanson, 2008, Neuro-oncology.

All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2

K. Hoang-Xuan, X. Wang, F. Ducray, 2010, Neurology.

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

K. Hoang-Xuan, M. Sanson, K. Mokhtari, 2006, Cancer.

Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.

Jean-Yves Delattre, François Ducray, Renaud Schiappa, 2011, Neuro-oncology.

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

K. Hoang-Xuan, H. Duffau, L. Capelle, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases.

K. Hoang-Xuan, C. Sautès-Fridman, K. Mokhtari, 2006, Blood.

Loss of 22q Chromosome is Related to Glioma Progression and Loss of 10q

K. Hoang-Xuan, M. Sanson, K. Mokhtari, 2006, Journal of Neuro-Oncology.

NOTCH2 Is Neither Rearranged nor Mutated in t(1;19) Positive Oligodendrogliomas

K. Hoang-Xuan, Y. Marie, M. Sanson, 2009, PloS one.

Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas.

K. Hoang-Xuan, Y. Marie, M. Sanson, 2007, Cancer genetics and cytogenetics.

Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma

K. Hoang-Xuan, Y. Marie, M. Sanson, 2009, Neuropathology and applied neurobiology.

Chromosome 1p loss: A favorable prognostic factor in low‐grade gliomas

K. Hoang-Xuan, H. Duffau, L. Capelle, 2005, Annals of neurology.

Chromosome 9p and 10q losses predict unfavorable outcome in low-grade gliomas.

K. Hoang-Xuan, Y. Marie, M. Sanson, 2010, Neuro-oncology.

Olig2 expression, GFAP, p53 and 1p loss analysis contribute to glioma subclassification

K. Hoang-Xuan, J. Hauw, Y. Marie, 2005, Neuropathology and applied neurobiology.